Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib
Andrea Loehr, Arif Hussain, Akash Patnaik, Alan H. Bryce, Daniel Castellano, Albert Font, Jeremy Shapiro, Jingsong Zhang, Brieuc Sautois, Nicholas J. Vogelzang, Gurkamal Chatta, Kevin D. Courtney, Andrea Harzstark, Francesco Ricci, Darrin Despain, Simon P. Watkins, Charmin King, Minh Nguyen, Andrew D. Simmons, Simon Chowdhury, Wassim Abida
Topics & Concepts
MedicineProstate cancerPARP inhibitorReversionOlaparibCancerOncologyGermlineInternal medicineCancer researchBRCA mutationBreast cancerGeneticsPoly ADP ribose polymeraseBiologyPhenotypeDNAGenePolymeraseProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentPARP inhibition in cancer therapy